U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

Physician payments are down slightly across the board, but they've fallen significantly for a handful of specialties. Researchers examined the long-term impact this trend could have on patient care.

The bioresorbable stent, examined at length for the LIFE-BTK clinical trial, stays in place for up to three years before completely dissolving. 

Infectious disease experts are ratcheting up their watchfulness of the H5N1 influenza virus. That’s because the strain of “bird flu” has continued turning up in domestic livestock.

STS risk calculators are known as a go-to resource for cardiologists, surgeons and any other healthcare providers who manage the care of heart patients. 

Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.

The Tricuspid Flow Optimizer was developed by Triflo Cardiovascular, a U.S.-based healthcare technology company founded by structural heart specialists.

An accidental discovery could have future implications for the material makeup for MRI contrast media.